Phrenic Nerve Palsy after Stereotactic Body Radiotherapy for Central Lung Cancer: A Case Report

IF 3.3 3区 医学 Q2 ONCOLOGY Clinical lung cancer Pub Date : 2025-01-01 DOI:10.1016/j.cllc.2024.10.006
James C.H. Chow, Jeannie Y.K. Chik, Ka Man Cheung, Luke T.Y. Lee, Kam Hung Wong, Kwok Hung Au
{"title":"Phrenic Nerve Palsy after Stereotactic Body Radiotherapy for Central Lung Cancer: A Case Report","authors":"James C.H. Chow,&nbsp;Jeannie Y.K. Chik,&nbsp;Ka Man Cheung,&nbsp;Luke T.Y. Lee,&nbsp;Kam Hung Wong,&nbsp;Kwok Hung Au","doi":"10.1016/j.cllc.2024.10.006","DOIUrl":null,"url":null,"abstract":"<div><div><ul><li><span>•</span><span><div>Radiation-induced phrenic nerve palsy is an uncommon complication of stereotactic body radiotherapy (SBRT) for central lung tumor. The resultant paralysis of hemidiaphragm can be symptomatic and compromise respiratory function.</div></span></li><li><span>•</span><span><div>The phrenic nerve can be delineated on planning computed tomography images using landmarks of the surrounding mediastinal structures. It should be considered a standard organ at-risk in thoracic SBRT where the planning target volume is in close proximity.</div></span></li><li><span>•</span><span><div>The dose-toxicity relationship of radiation-induced phrenic nerve palsy remains unclear. Nevertheless, the risk of palsy may be reduced by careful plan optimization, hotspot control within the planning target volume, respiratory motion management, and robust treatment verification.</div></span></li></ul></div></div>","PeriodicalId":10490,"journal":{"name":"Clinical lung cancer","volume":"26 1","pages":"Pages e1-e4"},"PeriodicalIF":3.3000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical lung cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1525730424002109","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

  • Radiation-induced phrenic nerve palsy is an uncommon complication of stereotactic body radiotherapy (SBRT) for central lung tumor. The resultant paralysis of hemidiaphragm can be symptomatic and compromise respiratory function.
  • The phrenic nerve can be delineated on planning computed tomography images using landmarks of the surrounding mediastinal structures. It should be considered a standard organ at-risk in thoracic SBRT where the planning target volume is in close proximity.
  • The dose-toxicity relationship of radiation-induced phrenic nerve palsy remains unclear. Nevertheless, the risk of palsy may be reduced by careful plan optimization, hotspot control within the planning target volume, respiratory motion management, and robust treatment verification.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中央型肺癌立体定向体放射治疗后的膈神经麻痹:病例报告。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical lung cancer
Clinical lung cancer 医学-肿瘤学
CiteScore
7.00
自引率
2.80%
发文量
159
审稿时长
24 days
期刊介绍: Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
期刊最新文献
Predicting Severe Radiation Pneumonitis in Patients With Locally-Advanced Non-Small-Cell Lung Cancer After Thoracic Radiotherapy: Development and Validation of a Nomogram Based on the Clinical, Hematological, and Dose-Volume Histogram Parameters. Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN). Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers. The Impact of Radiation Dose to Immune Cells in Stage IV Non-Small Cell Lung Cancer in the Era of Immunotherapy. The PESGA Trial: A Prospective, Open-Label, Single-Arm, Phase II Study to Evaluate First Line Therapy for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Patients, Treated by Induction Carboplatin/Etoposide/Pembrolizumab Followed by Maintenance of Pembrolizumab/ Sacituzumab Govitecan.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1